PATRICIA SCHRADER: Open Payments
NPI 1689022089 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,113 in 64 payments from 16 companies in 2025. Trend: 2023 $1,868 · 2024 $3,090 · 2025 $2,113
Food & beverage: $2,025Education: $88
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $799 |
| Celgene Corporation | 1 | $640 |
| Teva Pharmaceuticals USA, Inc. | 2 | $108 |
| PFIZER INC. | 5 | $82 |
| Lilly USA, LLC | 4 | $76 |
| Amneal Pharmaceuticals LLC | 3 | $74 |
| Grifols USA, LLC | 3 | $72 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| UCB, Inc. | 1 | $37 |
| Genentech USA, Inc. | 2 | $29 |
Products named: ZEPOSIA, QULIPTA, BOTOX, UBRELVY, VYALEV, NURTEC ODT, KISUNLA, CREXONT.
Industry payments across MO — which companies pay providers there.
